These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26183704)

  • 21. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-year death and loss to follow-up outcomes by source of referral to HIV care for HIV-infected patients initiating antiretroviral therapy in rural Mozambique.
    Blevins M; José E; Bilhete FR; Vaz LM; Shepherd BE; Audet CM; Vermund SH; Moon TD
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):198-207. PubMed ID: 25381732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life expectancy trends in adults on antiretroviral treatment in South Africa.
    Johnson LF; Keiser O; Fox MP; Tanser F; Cornell M; Hoffmann CJ; Prozesky H; Boulle A; Davies MA;
    AIDS; 2016 Oct; 30(16):2545-2550. PubMed ID: 27428744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men.
    Aliyu MH; Blevins M; Megazzini KM; Parrish DD; Audet CM; Chan N; Odoh C; Gebi UI; Muhammad MY; Shepherd BE; Wester CW; Vermund SH
    Int Health; 2015 Nov; 7(6):405-11. PubMed ID: 26012740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada.
    Palmer AK; Cescon A; Chan K; Cooper C; Raboud JM; Miller CL; Burchell AN; Klein MB; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Loutfy MR;
    J Int Assoc Provid AIDS Care; 2014; 13(1):56-62. PubMed ID: 24309754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history.
    Cescon A; Chan K; Raboud JM; Burchell AN; Forrest JI; Klein MB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS; Cooper C;
    AIDS; 2014 Jan; 28(1):121-7. PubMed ID: 24413263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet HIV; 2017 Aug; 4(8):e349-e356. PubMed ID: 28501495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-engagement in care of people living with HIV lost to follow-up after initiation of antiretroviral therapy in Mali: Who returns to care?
    Baldé A; Lièvre L; Maiga AI; Diallo F; Maiga IA; Costagliola D; Abgrall S
    PLoS One; 2020; 15(9):e0238687. PubMed ID: 32911516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Empirical estimation of life expectancy from a linked health database of adults who entered care for HIV.
    Schanzer D; Antoniou T; Kwong J; Timmerman K; Yan P
    PLoS One; 2018; 13(4):e0195031. PubMed ID: 29621255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
    Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
    Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration.
    Kassanjee R; Johnson LF; Zaniewski E; Ballif M; Christ B; Yiannoutsos CT; Nyakato P; Desmonde S; Edmonds A; Sudjaritruk T; Pinto J; Vreeman R; Dahourou DL; Twizere C; Kariminia A; Carlucci JG; Kasozi C; Davies MA;
    J Int AIDS Soc; 2021 Sep; 24 Suppl 5(Suppl 5):e25780. PubMed ID: 34546646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
    Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS
    AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada.
    Patterson S; Jose S; Samji H; Cescon A; Ding E; Zhu J; Anderson J; Burchell AN; Cooper C; Hill T; Hull M; Klein MB; Loutfy M; Martin F; Machouf N; Montaner J; Nelson M; Raboud J; Rourke SB; Tsoukas C; Hogg RS; Sabin C;
    HIV Med; 2017 Oct; 18(9):655-666. PubMed ID: 28440036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy.
    Guaraldi G; Cossarizza A; Franceschi C; Roverato A; Vaccher E; Tambussi G; Garlassi E; Menozzi M; Mussini C; Dʼarminio Monforte A
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):175-81. PubMed ID: 24442223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality Rate in a Cohort of People Living With HIV in Rural Tanzania After Accounting for Unseen Deaths Among Those Lost to Follow-up.
    Vanobberghen F; Weisser M; Kasuga B; Katende A; Battegay M; Tanner M; Glass On Behalf Of The Kiularco Study Group TR
    Am J Epidemiol; 2021 Feb; 190(2):251-264. PubMed ID: 33524120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
    Lloyd-Smith E; Brodkin E; Wood E; Kerr T; Tyndall MW; Montaner JS; Hogg RS
    AIDS; 2006 Feb; 20(3):445-50. PubMed ID: 16439879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Life expectancy after initiation of combination antiretroviral therapy in Thailand.
    Teeraananchai S; Chaivooth S; Kerr SJ; Bhakeecheep S; Avihingsanon A; Teeraratkul A; Sirinirund P; Law MG; Ruxrungtham K
    Antivir Ther; 2017; 22(5):393-402. PubMed ID: 28054931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
    Holmes CB; Sikazwe I; Sikombe K; Eshun-Wilson I; Czaicki N; Beres LK; Mukamba N; Simbeza S; Bolton Moore C; Hantuba C; Mwaba P; Phiri C; Padian N; Glidden DV; Geng E
    PLoS Med; 2018 Jan; 15(1):e1002489. PubMed ID: 29329301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
    Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
    Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.